Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
KLG - WK Kellogg Co - Stock Price Chart
TickerKLG [NYSE]
CompanyWK Kellogg Co
IndustryPackaged Foods
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume4.99M52W Range13.75 - 21.00
TodayInitiated Goldman Sell $11
TodayInitiated Exane BNP Paribas Neutral $14
AXDX - Accelerate Diagnostics Inc - Stock Price Chart
CompanyAccelerate Diagnostics Inc
IndustryMedical Devices
Market Cap93.12MEPS (ttm)-8.01
P/E-EPS this Y6.84%
Forward P/E-EPS next Y54.97%
PEG-EPS past 5Y8.41%
P/S7.99EPS next 5Y30.00%
P/B-EPS Q/Q-22.37%
Dividend-Sales Q/Q-24.35%
Insider Own47.86%Inst Own15.60%
Insider Trans-0.87%Inst Trans-
Short Float4.71%EarningsAug 10/a
Analyst Recom2.00Target Price40.00
Avg Volume24.21K52W Range4.50 - 17.80
BBAI - Holdings Inc - Stock Price Chart
TickerBBAI [NYSE, RUT] Holdings Inc
IndustryInformation Technology Services
Market Cap218.16MEPS (ttm)-0.69
P/E-EPS this Y65.53%
Forward P/E-EPS next Y38.93%
PEG-EPS past 5Y-
P/S1.35EPS next 5Y-
P/B-EPS Q/Q74.22%
Dividend-Sales Q/Q2.25%
Insider Own68.93%Inst Own10.96%
Insider Trans-9.18%Inst Trans-28.41%
Short Float14.19%EarningsAug 08/a
Analyst Recom2.20Target Price3.67
Avg Volume3.24M52W Range0.58 - 6.77
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
CompanyEledon Pharmaceuticals Inc
Market Cap34.89MEPS (ttm)-6.12
P/E-EPS this Y68.91%
Forward P/E-EPS next Y25.77%
PEG-EPS past 5Y31.69%
P/S-EPS next 5Y-
P/B0.36EPS Q/Q38.44%
Dividend-Sales Q/Q-
Insider Own6.01%Inst Own42.08%
Insider Trans0.00%Inst Trans-2.38%
Short Float0.15%EarningsAug 10/b
Analyst Recom1.00Target Price14.80
Avg Volume64.94K52W Range1.08 - 3.70
Oct-02-23 07:00AM Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors (GlobeNewswire) +13.14%
Sep-25-23 07:00AM Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human (GlobeNewswire)
Sep-20-23 04:05PM Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Sep-11-23 07:00AM Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors (GlobeNewswire)
Sep-06-23 07:00AM Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates (GlobeNewswire) -11.89%
Sep-05-23 07:00AM Eledon Pharmaceuticals Announces First Participant Dosed in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Rejection in Kidney Transplantation (GlobeNewswire)
Aug-16-23 07:00AM Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation (GlobeNewswire)
Aug-10-23 07:00AM Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Jul-12-23 07:30AM Amerigo Reports Q2-2023 Production Results and Provides MVC Operational Update (GlobeNewswire)
Jun-02-23 08:00AM Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference (GlobeNewswire)
FNGR - FingerMotion Inc - Stock Price Chart
CompanyFingerMotion Inc
IndustryTelecom Services
Market Cap363.93MEPS (ttm)-0.16
P/E-EPS this Y70.59%
Forward P/E233.33EPS next Y-
PEG-EPS past 5Y-2.69%
P/S8.80EPS next 5Y-
P/B26.04EPS Q/Q27.22%
Dividend-Sales Q/Q150.64%
Insider Own48.57%Inst Own1.29%
Insider Trans9.31%Inst Trans-7.08%
Short Float5.76%Earnings-
Analyst Recom1.00Target Price5.00
Avg Volume955.68K52W Range1.01 - 9.80
OPAD - Offerpad Solutions Inc - Stock Price Chart
CompanyOfferpad Solutions Inc
IndustryReal Estate Services
Market Cap225.46MEPS (ttm)-1.80
P/E-EPS this Y60.54%
Forward P/E-EPS next Y57.01%
PEG-EPS past 5Y-
P/S0.10EPS next 5Y-
P/B1.69EPS Q/Q-
Dividend-Sales Q/Q-78.68%
Insider Own61.38%Inst Own13.19%
Insider Trans0.54%Inst Trans-24.48%
Short Float7.79%EarningsAug 02/b
Analyst Recom2.71Target Price8.38
Avg Volume72.78K52W Range5.63 - 19.35
PTN - Palatin Technologies Inc. - Stock Price Chart
TickerPTN [AMEX]
CompanyPalatin Technologies Inc.
Market Cap19.70MEPS (ttm)-2.53
P/E-EPS this Y30.04%
Forward P/E-EPS next Y72.88%
PEG-EPS past 5Y-
P/S4.06EPS next 5Y-
P/B148.70EPS Q/Q31.69%
Dividend-Sales Q/Q128.60%
Insider Own8.70%Inst Own7.63%
Insider Trans0.00%Inst Trans14.22%
Short Float4.19%EarningsSep 28/b
Analyst Recom1.00Target Price83.33
Avg Volume93.09K52W Range1.43 - 6.40
NAMS - NewAmsterdam Pharma Company NV - Stock Price Chart
CompanyNewAmsterdam Pharma Company NV
Market Cap693.13MEPS (ttm)-0.20
P/E-EPS this Y-77.09%
Forward P/E-EPS next Y24.95%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.50EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own59.38%Inst Own26.83%
Insider Trans0.00%Inst Trans3.58%
Short Float0.98%EarningsAug 07/b
Analyst Recom1.00Target Price24.37
Avg Volume106.03K52W Range7.52 - 32.88
Sep-21-23 07:00AM NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimers Disease Who Carry an ApoE4 Mutation (GlobeNewswire)
Sep-20-23 08:00AM NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Aug-14-23 04:01PM NewAmsterdam Pharma Announces Appointment of William BJ Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer (GlobeNewswire)
Aug-10-23 06:01AM NewAmsterdam Pharma First Half 2023 Earnings: 0.92 loss per share (vs 1.50 profit in 1H 2022) (Simply Wall St.)
Aug-07-23 07:15AM NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights (GlobeNewswire)
Jul-25-23 04:01PM NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia and/or Established Atherosclerotic Cardiovascular Disease (GlobeNewswire)
Jun-09-23 04:01PM NewAmsterdam Pharma Announces Closing of Upsized Secondary Offering of Ordinary Shares (GlobeNewswire)
Jun-06-23 11:25PM NewAmsterdam Pharma Announces Pricing of Upsized Secondary Offering of Ordinary Shares (GlobeNewswire)
04:01PM NewAmsterdam Pharma Announces Commencement of Secondary Offering of Ordinary Shares (GlobeNewswire)
Jun-05-23 07:00AM NewAmsterdam Pharma Announces Positive Topline Results from Phase 2b Dose-Finding Trial Evaluating Obicetrapib in Japanese Patients (GlobeNewswire)
FRLN - Freeline Therapeutics Holdings plc ADR - Stock Price Chart
CompanyFreeline Therapeutics Holdings plc ADR
CountryUnited Kingdom
Market Cap16.61MEPS (ttm)-12.16
P/E-EPS this Y95.71%
Forward P/E-EPS next Y1.60%
PEG-EPS past 5Y-
P/S26.79EPS next 5Y-
P/B0.40EPS Q/Q33.85%
Dividend-Sales Q/Q-
Insider Own4.96%Inst Own53.82%
Insider Trans0.00%Inst Trans-1.70%
Short Float2.49%EarningsAug 15/b
Analyst Recom1.50Target Price9.50
Avg Volume363.70K52W Range2.11 - 12.00
DYN - Dyne Therapeutics Inc - Stock Price Chart
CompanyDyne Therapeutics Inc
Market Cap484.50MEPS (ttm)-3.41
P/E-EPS this Y-7.43%
Forward P/E-EPS next Y10.09%
PEG-EPS past 5Y-135.08%
P/S-EPS next 5Y-
P/B2.34EPS Q/Q-7.17%
Dividend-Sales Q/Q-
Insider Own47.06%Inst Own61.40%
Insider Trans-1.43%Inst Trans-4.54%
Short Float17.02%EarningsAug 03/b
Analyst Recom1.00Target Price29.38
Avg Volume420.67K52W Range8.04 - 15.60